BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	184,409.67 393.48M	-0.61% -1133.34
ALLSHR	110,382.58 1,026.61M	-0.45% -501.36
KSE30	56,593.88 158.22M	-0.71% -404.12
KMI30	259,208.41 213.19M	-0.87% -2263.77
KMIALLSHR	70,710.78 493.25M	-0.60% -427.51
BKTi	53,774.72 51.55M	-0.55% -299.43
OGTi	36,045.04 14.71M	-0.59% -214.34

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	90,645.00	92,275.00 89,825.00	-460.00 -0.50%
BRENT CRUDE	63.02	63.92 61.83	1.03 1.66%
RICHARDS BAY COAL MONTHLY	86.75	0.00 0.00	-1.25 -1.42%
ROTTERDAM COAL MONTHLY	95.30	98.65 95.30	-2.90 -2.95%
USD RBD PALM OLEIN	1,027.50	1,027.50 1,027.50	0.00 0.00%
CRUDE OIL - WTI	58.78	59.77 57.61	1.02 1.77%
SUGAR #11 WORLD	14.89	14.99 14.78	-0.08 -0.53%